Panel Discussion: Accelerating our Ability to Unearth the Mechanism of Action of Biomarkers
Time: 3:00 pm
day: Conference Day One - Track One - PM
Details:
- What are some of the major challenges for identifying and understanding biomarker MOA?
- How are researchers developing a better test earlier?
- How are we overcoming the upfront investment?
- What are the key challenges for validating different sets of biomarkers?
- Why is sampling so important?
- At what stage do we need to begin thinking about the CDx?
- What platforms are being used and are they compliant?